Precision for Medicine
Deborah Phippard, PhDChief Scientific Officer
Deborah Phippard is a hharma industry veteran and expert at biomarker-driven clinical trial design and execution. Led biomarker and drug development programs for pharmaceutical and diagnostics companies, as well as the National Institutes of Health. Spearheaded the discovery of pharmacodynamic biomarkers and novel targets for inflammatory disease therapy.
Insights from Deborah Phippard, PhD
Research & Development | Article
Are Rare Brain Diseases the Next Commercial Frontier for Gene Therapy?
Research & Development | Article
CGT Is In Its Infancy For CNS Disorders, But Technical Strides Being Made
Research & Development | Industry Brief
Understanding Immunogenicity and AAV Gene Therapy
Research & Development | White Paper
Exploring the Intricacies of the Immune System: A Practical Guide to Immune Monitoring Across Therapeutic Interventions
Research & Development | Industry Brief
Immune Cell Profiling in Translational Research
Research & Development | Poster
Utilization of Multiparameter Flow Cytometry for Immune Monitoring of Tumor Infiltrating Lymphocytes Isolated from Fresh Tumor Tissue
Research & Development | Poster
PD-L1 Expression on Immune Cells from Solid Tumor Patients: Implications for Tumor Immunity and Immunotherapy
Research & Development | Poster
Validation of an approach to measure high levels of neutralizing antibodies against AAV in human serum samples